1. Centers for Disease Control and Prevention (2017) Surveillance for viral hepatitis—United States. Retrieved July 6, 2019, from https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm.
2. Ng, M. H., Chou, J. Y., Chang, T. J., et al. (2013). High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Addictive Behaviors,38(4), 2089–2093.
3. Porter, J. C., Lusk, H. M., & Katz, A. R. (2014). Prevalence of HCV infection among clients in community-based health settings in Hawaii, 2002–2010: Assessing risk factors. American Journal of Public Health,104(8), 1534–1539.
4. United States Preventive Task force (2013) Hepatitis C screening. Retrieved August 12 2019, from https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/hepatitis-c-screening.
5. Maryland Department of Health (2019) Maryland hepatitis C strategic plan. Retrieved August 8 2019, from https://phpa.health.maryland.gov/OIDPCS/AVHPP/AVHPP%20Documents/2019MarylandHepatitisCStrategicPlan.pdf.